Biological Safety Testing Market Growth with a CAGR of 10.9% Through 2033
The Biological Safety Testing Market is set to experience significant growth, with its market size projected to reach approximately USD 13.4 billion by 2033, up from USD 4.8 billion in 2023. This expansion, driven by a Compound Annual Growth Rate (CAGR) of 10.9% from 2024 to 2033, reflects the increasing demand for rigorous safety assessments in the pharmaceutical and biotechnology sectors. Several factors contribute to this robust growth. The rising prevalence of chronic diseases and the subsequent surge in biopharmaceutical production have heightened the need for comprehensive safety testing. The development and widespread adoption of novel biologics, such as gene…
- Date: May 28, 2024
- Author: Robert Shaw
- Category: PharmiWeb